Yicai's report says patients in China will have to pay the full price for the treatment, as the drug has not been included in the national healthcare insurance
This case report highlights the need for continued, perhaps increased, regulation of access to not-yet-approved pharmaceuticals because of potentially deleterious adverse effects that can result from their unregulated use, Komolafe wrote in his paper, published last month in the Annals of Internal Medicine Clinical Cases
Not on any medication that could interact badly with these injections
Lewis, Boca Raton, pp 469519 Monostori P, Wittmann G, Karg E, Tri S (2009) Determination of glutathione and glutathione disulfide in biological samples: an in-depth review
Description BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a naturally occurring protein in human gastric juice
Alzheimer's disease failed clinical trials